Takara Bio Inc
Takara Bio Inc., together with its subsidiaries, operates as a biotechnology company in Japan and internationally. It operates through Bioindustry and Gene Therapy segments. The company develops original research reagents and scientific instruments; and provides contracted services that utilize new genetic engineering and cell engineering technologies, supporting life sciences, and bioindustry field that range from basic research to drug discovery and development. Its contracted services include development of virus vectors and cells for gene transduction based on good gene, cellular and tissue-based product manufacturing practices, and good manufacturing practices; quality and safety testing services; and production and storage of cell banks. The company also provides a package of regenerative medicine development and genetic testing support services, such as genetic analysis. In addition, it engages in the development and commercialization of various gene therapies, including oncolytic virus utilizing Canerpaturev, which is an attenuated strain of the herpes simplex virus that exhibits antitumor activity when inserted into a cancerous region; siTCR gene therapy, which is in Phase I/II clinical trials for the treatment of synovial sarcoma; and CD19 chimeric antigen receptors gene therapy for the treatment of adult acute lymphocytic leukemia. Additionally, the company offers RetroNectin for gene transduction. The company was founded in 2002 and is headquartered in Kusatsu, Japan. Takara Bio Inc. is a subsidiary of Takara Holdings Inc. Show More...
-
Website http://www.takara-bio.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 4.48 EUR
-
Last Updated 29-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-03 2011-03 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 TTM Earnings Per Share JPY 5.23 5.37 9.06 12.89 12.45 8.01 11.08 11.24 19.39 30.38 35.52 Dividends JPY 1.0 1.1 1.1 1.5 1.5 4.0 4.5 7.0 7.0 Payout Ratio % * 9.1 9.8 15.4 10.8 7.9 55.9 16.2 19.7 Shares Mil 113.0 113.0 113.0 113.0 118.0 120.0 120.0 120.0 120.0 120.0 120.0 Book Value Per Share * EUR 2.84 3.04 2.86 3.23 3.66 3.88 4.05 3.8 4.21 4.51 Free Cash Flow Per Share * EUR 0.07 0.16 -0.010 -0.1 -0.22 0.13 0.08 0.24 Return on Assets % 1.36 1.4 2.36 3.22 2.69 1.49 2.01 2.02 3.43 5.23 6.0 Financial Leverage (Average) 1.15 1.13 1.15 1.13 1.1 1.12 1.11 1.12 1.11 1.11 1.11 Return on Equity % 1.58 1.6 2.69 3.67 2.99 1.65 2.23 2.26 3.84 5.81 6.69 Return on Invested Capital % 1.32 1.45 2.5 3.47 2.81 1.49 2.03 2.13 3.77 5.7 6.55 Interest Coverage 78.44 140.71 416.5 325.0 313.14 226.55 177.89 Current Ratio 7.06 8.82 7.79 7.83 9.56 6.7 7.76 7.3 6.1 5.86 6.38 Quick Ratio 5.98 7.64 6.77 6.73 8.28 5.63 6.62 6.23 4.8 4.59 4.73 Debt/Equity 0.010 0.010 0.010 0.010